← Weekly issues
Week of 2026-11-16
2026-W47 · 2026-11-16 – 2026-11-22 · 66 findings
in progress
news report
Could microdosing GLP-1 drugs boost longevity?
Scientific American examines the emerging trend and speculative rationale behind microdosing GLP-1 receptor agonists to promote longevity while avoiding full-dose gastrointestinal side effects and excessive weight loss.
observational
The plasma proteins GSN, F2, CRTAC1, and HP are associated with multigenerational health, longevity, and resilience.
Circulating levels of the plasma proteins GSN, F2, CRTAC1, and HP consistently mark familial longevity, improved cardiometabolic healthspan, and extended mid- to late-life survival in humans.
review
Vascular Senescence and Atherosclerotic Plaque Vulnerability
DNA damage and mitochondrial dysfunction drive vascular cellular senescence and the senescence-associated secretory phenotype, promoting atherosclerotic plaque vulnerability that can potentially be tracked via peripheral markers of cellular aging.
review
Satellite cell attrition and skeletal muscle aging.
Satellite cell deterioration and microenvironmental decay drive skeletal muscle aging through telomere attrition, mitochondrial dysfunction, epigenetic dysregulation, and altered signaling pathways.
news report
Fight Aging! Newsletter, November 16th 2026
Fight Aging! presents weekly curated commentary on aging biology and industry developments, highlighting evidence of stagnant cerebrospinal fluid flow in Alzheimer's disease.